Home/Filings/4/0001437749-22-019665
4//SEC Filing

Furlow Brenda S. 4

Accession 0001437749-22-019665

CIK 0000842023other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 6:59 PM ET

Size

33.1 KB

Accession

0001437749-22-019665

Insider Transaction Report

Form 4
Period: 2022-08-07
Furlow Brenda S.
SVP - General Counsel
Transactions
  • Gift

    Common Stock

    2021-10-261,3304,960 total
  • Tax Payment

    Common Stock

    2022-08-07$382.97/sh969$371,0985,960 total
  • Gift

    Common Stock

    2021-10-261,3306,290 total
  • Gift

    Common Stock

    2021-10-26+1,3301,330 total(indirect: By Trust)
  • Gift

    Common Stock

    2021-10-26+1,3301,330 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock

    2022-08-07+1,9696,929 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-08-071,9690 total
    Common Stock (1,969 underlying)
Holdings
  • Stock Options (Right to Buy)

    Exercise: $190.41Exp: 2026-08-07Common Stock (9,968 underlying)
    9,968
  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05Common Stock (7,492 underlying)
    7,492
  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05Common Stock (9,990 underlying)
    9,990
  • Stock Options (Right to Buy)

    Exercise: $481.82Exp: 2028-08-06Common Stock (6,080 underlying)
    6,080
  • Stock Options (Right to Buy)

    Exercise: $108.49Exp: 2022-08-07Common Stock (921 underlying)
    921
  • Stock Options (Right to Buy)

    Exercise: $177.32Exp: 2025-08-08Common Stock (7,339 underlying)
    7,339
  • Restricted Stock Units

    Common Stock (1,679 underlying)
    1,679
  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05Common Stock (8,325 underlying)
    8,325
  • Stock Options (Right to Buy)

    Exercise: $372.44From: 2022-08-31Exp: 2028-03-01Common Stock (10,997 underlying)
    10,997
  • Stock Options (Right to Buy)

    Exercise: $125.05Exp: 2024-08-09Common Stock (9,503 underlying)
    9,503
  • Stock Options (Right to Buy)

    Exercise: $177.32Exp: 2025-08-08Common Stock (9,786 underlying)
    9,786
  • Stock Options (Right to Buy)

    Exercise: $190.41Exp: 2026-08-07Common Stock (13,290 underlying)
    13,290
  • Stock Options (Right to Buy)

    Exercise: $481.82Exp: 2028-08-06Common Stock (4,560 underlying)
    4,560
  • Stock Options (Right to Buy)

    Exercise: $267.87Exp: 2027-08-05Common Stock (8,325 underlying)
    8,325
  • Restricted Stock Units

    Common Stock (1,167 underlying)
    1,167
Footnotes (10)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F10]Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
  • [F2]Fully exercisable.
  • [F3]On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs.
  • [F4]Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
  • [F5]Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F6]Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.
  • [F7]Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
  • [F8]Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
  • [F9]Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001443851

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:59 PM ET
Size
33.1 KB